Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity.

Liu Z, Han C, Dong C, Shen A, Hsu E, Ren Z, Lu C, Liu L, Zhang A, Timmerman C, Pu Y, Wang Y, Chen M, Qiao J, Fu YX.

Sci Immunol. 2019 Aug 9;4(38). pii: eaav6473. doi: 10.1126/sciimmunol.aav6473.

PMID:
31399492
2.

NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance.

Li X, Liu Z, Zhang A, Han C, Shen A, Jiang L, Boothman DA, Qiao J, Wang Y, Huang X, Fu YX.

Nat Commun. 2019 Jul 19;10(1):3251. doi: 10.1038/s41467-019-11238-1.

3.

Targeting Tumors with IL-10 Prevents Dendritic Cell-Mediated CD8+ T Cell Apoptosis.

Qiao J, Liu Z, Dong C, Luan Y, Zhang A, Moore C, Fu K, Peng J, Wang Y, Ren Z, Han C, Xu T, Fu YX.

Cancer Cell. 2019 Jun 10;35(6):901-915.e4. doi: 10.1016/j.ccell.2019.05.005.

PMID:
31185213
4.
5.

Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy.

Luo M, Liu Z, Zhang X, Han C, Samandi LZ, Dong C, Sumer BD, Lea J, Fu YX, Gao J.

J Control Release. 2019 Apr 28;300:154-160. doi: 10.1016/j.jconrel.2019.02.036. Epub 2019 Mar 4.

PMID:
30844475
6.
7.

Targeting tumor cells with antibodies enhances anti-tumor immunity.

Sun Z, Fu YX, Peng H.

Biophys Rep. 2018;4(5):243-253. doi: 10.1007/s41048-018-0070-2. Epub 2018 Oct 29.

8.

T cell-derived lymphotoxin limits Th1 response during HSV-1 infection.

Yang K, Liang Y, Sun Z, Liu L, Liao J, Xu H, Zhu M, Fu YX, Peng H.

Sci Rep. 2018 Dec 7;8(1):17727. doi: 10.1038/s41598-018-36012-z.

9.

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance.

Liang Y, Tang H, Guo J, Qiu X, Yang Z, Ren Z, Sun Z, Bian Y, Xu L, Xu H, Shen J, Han Y, Dong H, Peng H, Fu YX.

Nat Commun. 2018 Nov 2;9(1):4586. doi: 10.1038/s41467-018-06890-y.

10.

Non-canonical NF-κB Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy.

Hou Y, Liang H, Rao E, Zheng W, Huang X, Deng L, Zhang Y, Yu X, Xu M, Mauceri H, Arina A, Weichselbaum RR, Fu YX.

Immunity. 2018 Sep 18;49(3):490-503.e4. doi: 10.1016/j.immuni.2018.07.008. Epub 2018 Aug 28.

PMID:
30170810
11.

Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion.

Liu X, Liu L, Ren Z, Yang K, Xu H, Luan Y, Fu K, Guo J, Peng H, Zhu M, Fu YX.

Cell Rep. 2018 Aug 21;24(8):2101-2111. doi: 10.1016/j.celrep.2018.07.062.

12.

T Cell-Derived Lymphotoxin Is Essential for the Anti-Herpes Simplex Virus 1 Humoral Immune Response.

Yang K, Liang Y, Sun Z, Xue D, Xu H, Zhu M, Fu YX, Peng H.

J Virol. 2018 Jun 29;92(14). pii: e00428-18. doi: 10.1128/JVI.00428-18. Print 2018 Jul 15.

13.

Immune Evasion in Tumor's Own Sweet Way.

Tang H, Fu YX.

Cell Metab. 2018 May 1;27(5):945-946. doi: 10.1016/j.cmet.2018.03.013. Epub 2018 Apr 5.

14.

Another way to not get eaten.

Zhang CC, Fu YX.

Nat Immunol. 2018 Jan;19(1):6-7. doi: 10.1038/s41590-017-0009-7. No abstract available.

PMID:
29242546
15.

Effect of Shen Song Yang Xin Capsule on Myocardial Electrophysiology of Acute Atrial Fibrillation in Canine Model.

Zhang K, Shi L, Tang HJ, Yang L, Yang XC.

Chin Med J (Engl). 2017 Oct 20;130(20):2513-2514. doi: 10.4103/0366-6999.216404. No abstract available.

16.

Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling.

Xu MM, Pu Y, Han D, Shi Y, Cao X, Liang H, Chen X, Li XD, Deng L, Chen ZJ, Weichselbaum RR, Fu YX.

Immunity. 2017 Aug 15;47(2):363-373.e5. doi: 10.1016/j.immuni.2017.07.016. Epub 2017 Aug 8.

17.

Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammation.

Zhang Y, Kim TJ, Wroblewska JA, Tesic V, Upadhyay V, Weichselbaum RR, Tumanov AV, Tang H, Guo X, Tang H, Fu YX.

Cell Mol Immunol. 2018 Jul;15(7):697-709. doi: 10.1038/cmi.2017.25. Epub 2017 Jun 5.

18.

Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression.

Liao J, Luan Y, Ren Z, Liu X, Xue D, Xu H, Sun Z, Yang K, Peng H, Fu YX.

Cancer Immunol Res. 2017 Jul;5(7):560-570. doi: 10.1158/2326-6066.CIR-16-0221. Epub 2017 May 22.

19.

DNA sensing and immune responses in cancer therapy.

Qiao J, Tang H, Fu YX.

Curr Opin Immunol. 2017 Apr;45:16-20. doi: 10.1016/j.coi.2016.12.005. Epub 2017 Jan 12. Review.

PMID:
28088707
20.

Cutting Edge: Lymphotoxin Signaling Is Essential for Clearance of Salmonella from the Gut Lumen and Generation of Anti-Salmonella Protective Immunity.

Wroblewska JA, Zhang Y, Tang H, Guo X, Nagler C, Fu YX.

J Immunol. 2017 Jan 1;198(1):55-60. Epub 2016 Dec 2.

Supplemental Content

Loading ...
Support Center